Genus plc (LON:GNS - Get Free Report) shares crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 1,774.07 ($24.01) and traded as high as GBX 2,100 ($28.42). Genus shares last traded at GBX 2,100 ($28.42), with a volume of 42,596 shares.
Wall Street Analysts Forecast Growth
Separately, Shore Capital restated a "buy" rating on shares of Genus in a research report on Wednesday, April 30th.
Check Out Our Latest Stock Analysis on Genus
Genus Stock Up 1.6%
The stock has a market capitalization of £1.33 billion, a PE ratio of 168.27, a P/E/G ratio of 2.87 and a beta of 0.37. The firm has a 50 day moving average of GBX 1,851.66 and a two-hundred day moving average of GBX 1,773.81. The company has a current ratio of 1.80, a quick ratio of 1.08 and a debt-to-equity ratio of 53.12.
Genus (LON:GNS - Get Free Report) last released its quarterly earnings data on Thursday, February 27th. The company reported GBX 39.80 ($0.54) earnings per share for the quarter. Genus had a return on equity of 1.41% and a net margin of 1.18%. Equities research analysts anticipate that Genus plc will post 70.9644323 earnings per share for the current year.
Insider Transactions at Genus
In other news, insider Jorgen Kokke sold 19,967 shares of Genus stock in a transaction on Friday, February 28th. The stock was sold at an average price of GBX 1,731 ($23.42), for a total transaction of £345,628.77 ($467,697.93). Corporate insiders own 0.75% of the company's stock.
About Genus
(
Get Free Report)
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Featured Stories
Before you consider Genus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.
While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
